CASR and vibrio infectious disease: Nonetheless, the ability of CaSR agonists to reduce cholera toxin-induced fluid secretion demonstrated in this and other studies highly suggests that this class of nutrients and drugs may provide a unique therapy for cholera and other secretory diarrheal diseases.